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The human Ig heavy chain variable region gene (VH) locus has been studied in
considerable detail at the structural level ; it contains -100-200 Ig heavy chainVH
genes that have been grouped into six families (denoted VH1 through VH6) based
on amino acid and nucleic acid sequence similarities (1-7) . The different families
range in size from 1 member (VH6) to >25 members (VH3) and contain both func-
tional genes and pseudogenes, interspersed over the entire 2,000-kb locus (2-4, 6) .
The contribution of different Ig heavy and light chain variable region gene seg-
ments to antibodies of particular specificity has been extensively characterized in
murine systems (8-12) . In contrast to the murine system, little is known about VH
gene utilization in different human B-lineage cell populations or in antibodies of
particular specificity and function (reviewed in reference 13). To begin to charac-
terize the contribution of human VH gene segments to antibody specificities, we
have screened antibodies produced from a large panel of IgM-secreting, EBV
transformed human B cell lines forVH gene utilization and antigen-binding pat-
tern . The results show that there is no obvious correlation betweenantigen-binding
pattern and expression ofmembers of the familiesVH1VH5. In contrast, antibodies
encoded by theVH6 gene family displayed bindingpatterns reminiscent of autoan-
tibodies present in the sera of patients with SLE. Nucleotide sequence analysis re-
vealed that both germline and somatically mutatedVH6 genes are expressed in these
antibodies and that the third complementarity-determining region (CDR3)t is con-
served in length.
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Materials and Methods
EBV-transformed Cell Lines.
￿
Mononuclear cellsfrom peripheral blood, obtained from three
healthy volunteers and from 130-d-old fetal liver and spleen were prepared and depleted of
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T cells as described previously (14). EBVtransformed cell lines were generated under lim-
iting dilution conditions as described previously (15).
ELISAs.
￿
Culture supernatants ofEBVtransformed cell lineswere screened for reactivity
against a panel of25 antigens using direct binding ELISA assays. The panel ofantigens con-
sisted ofBSA, dinitrophenol-BSA, trinitrophenol-BSA, arsonate-BSA, fluorescein-BSA, human
IgG, humanthyroglobulin, human insulin, ovalbumin, hen egglysozyme (Hel), tetanus toxoid,
rabies virus, cytochrome c (Cyt c), diptheria toxoid, native DNA (nDNA), single-stranded
DNA (ssDNA), poly(dT) (PdT), poly(A:U), bovine heart cardiolipin (Card), RNA, smRNP,
pooled pneumococcal polysaccharide (Pneumovax), al, 6dextran and Haemophilus in fluenzae
type b capsular polysaccharide. Controls, coating, and assay conditions were described else-
where (14-17; and Logtenberg, T., manuscript submitted for publication). Binding was
confirmed in liquid phase inhibition ELISA as described elsewhere (18); immunopurified
IgM or crudeculture supernatant was preincubated with varying concentrations ofcompet-
itor and assayed for residual binding to solid-phase bound antigen. The concentration of
competitor required for 50% inhibition reflects the relative avidity of the antibody for the
competitor.
Northern Blotting.
￿
Total RNA from each cell line was separated on a I% agarose gel and
analyzed by Northern blotting for hybridization to probes specific for each of the six known
human VH gene families as described previously (6, 15).
cDNA Cloning and Sequencing
￿
cDNA cloning and dideoxy sequencing were carried out
as described (19, 20) with two modifications: (a) the starting material for cDNA synthesis
was 50 t~g of total cellular RNA and (b) blunt-ended cDNAs were cloned into Bluescript
(Stratagene, La Jolla, CA). In each case both strands of cloned cDNA were sequenced.
Pblymerase Chain Reaction (PCR).
￿
DNA was amplified by using the Perkin-Elmer Cetus
(Norwalk, CT) GeneAmp Kit using Taq 1 polymerase. 2 tug genomic DNA in polymerase
buffer was mixed with appropriate primers (final concentration 1 pM) and subjected to 35 cycles
of PCR, each consisting of 1 min of denaturation at 94°C, 2 min of cooling to 37°C and
3 min of extension at 72°C. After each cycle the extension time was increased by 5 s. After
amplification, one-tenth ofthe reaction volume was subjected to electrophoresis on a 117c agarose
gel, blotted to ZetaProbe membranes and probed with the 32p-labeled VH6 probe. Primers
used were TL20 5' TCCAAGTGGTATAATG 3, TL21 5' TCCAAGTGGAATACTA 3, TL22
5' TCTTGCACAGTAATACAC 3'.
Results and Discussion
VH Gene Utilization in EBV-transformed Cell Lines.
￿
We established 187 monoclonal
IgM-secreting human B cell lines by EBV transformation of B cells (under limiting
dilution conditions) from peripheral blood ofthreehealthyadults (97 cell lines), from
a 130-d-oldfetalliver(36cell lines), and from an adult spleen (54cell lines; reference
15). RNA from these cell lines hybridized to only one of the VH probes and the fre-
quency of VH gene utilization in both adult and fetal tissue-derived collections
roughly correlated with the complexity of each family (15).
Antibodies from VH6-expressing Cell Lines Bind to DNA.
￿
Antigen binding proper-
ties ofIgM molecules secreted by the 187 cell lineswere assayedby screening culture
supernatants in direct binding ELISA for reactivity against a panel of 24 antigens.
A number of antibodies that used heavy chains containing VH segments from fam-
ilies 1-5 boundto particular antigens within thepanel (Logtenberg, T, unpublished
data); however, there was no obvious correlation between antigen-binding patterns
and expression of these VH gene families (not shown). In contrast, antibodies from
each of the four VH6-expressing cell lines in the collection bound to ssDNA and
PdT Binding to polynucleotides was not simply a matter of interaction with nega-
tively charged molecules because no bindingwasobserved to similarly charged mol-
ecules such as RNA and poly(A:U) (Table I, legend). Two of these clonal cell linesLOGTENBERG ET AL.
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TABLE I
Ongin of Vx6-expressing EBV-transformed B Cell Lines and Properties of
the Antibodies They Secrete
Liver and spleen cells from a130-d-old fetus andmononudear peripheral blood cells from three
adults were transformed with EBV under limiting dilution conditions. Supernatants from
monoclonal IgM-secreting Bcelllines were tested in direct binding ELISAfor reactivity against
apanel of 24 antigens (see Materials andMethods). Results obtained from the direct binding
assay were confirmed in liquid phase inhibition ELISAs with 'immunopurified antibodies or
tcrude supernatant. Control competitor antigens included IgG, smRNP, and RNA. Results
are expressed as the concentration of competitor required for 50% inhibition of binding to
the solid phase-bound antigen. PB, peripheral blood; FL, fetal liver; FS, fetal spleen. S Indi-
cates lack of binding to solid phase-bound antigen.
produced Klight chains with variable regions from different Vu subgroups (Logten-
berg, T, unpublished data) and the other two produced X light chains (Table I).
Therefore, the common binding activities were independent ofthelight chain used
by the antibodies. The VH6 antibodies from individual clones also displayed var-
ious patterns of binding activities with a limited number of antigens in the panel,
notably native DNA, cardiolipin, Cytcand lysozyme. Such polyreactivity is a char-
acteristic of some anti-DNA mAbs of both murine and human origin (reviewed in
reference 21).
Germline and Somatically Mutated Vx6 Gene Segments in Anti-DNA Autoantibodies.
￿
The
molecular basis of the observed similarities and differences in antigen binding pat-
terns of antibodies secreted by .V146-expressing cell lines was investigated by
analyzing cDNA clones of the Ig heavy chain mRNA expressed by each cell line.
Comparison of the nucleotide sequences of the VH6 genes expressed by fetal
tissue-derived lines L16 and MLl to that of a germline VH6 segment (6-1G1; refer-
ence 6) revealed 100To homology (Fig. 1). An identicalnucleotide sequence has been
obtained from four additional germline VH6 segments from unrelated individuals,
demonstrating that the human VH6 segment is highly conserved in the outbred
human population (22, 23 ; and Logtenberg, T, unpublished). The VH regions ex-
pressedby theadultperipheral bloodlymphocyte-derived linesA10 and A431 differed
from the prototypic germline sequence by three and six nucleotides, respectively
(Fig. 1). Eight of the nine differences were concentrated in the CDRI and CDR2
(antigen contact) regions of the VH segment, and in each case, resulted in amino
acid replacements (Fig. 2).
The pattern and extent ofnucleotide substitutions in the A10 and A431 VH6 genes
suggested somatic mutations (24). To confirm this possibility, we used the PCR to
determinewhetherthe "mutated" CDR2 sequence of cell line A431 existed in germ-
line DNA from the same donor. PCR reactions used a common 3' primer (TL22)
that represented sequences conserved in both germline and mutated VH6 genes and
Clone no. Origin Isotype ssDNA nDNA
Antigen
Card PdT Cyt c Hel
,aglml
A10' adult PB IgM,x 5.0 0.02 0.1 0.02 S 0.02
A431' adult PB IgM,X 5.0 0.3 0.2 5.0 2.0 -
L16" 130 d FL IgM,k 5.0 - 0.13 0.001 - -
ML1I 130 d FS IgM,u 2.5 - - 10.0 - -1350
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A10
A431
6-1G1
L16
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L16
KL1
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FRI
￿
10
GAG GTA GAG CTG CAG GAG TCA GGT CCA GGA CTG GTG AAG CCC TCG GAG
20
￿
30 CDR1>
ACC CTC TCA CTC ACC TGT GCC ATC TCC GGG GAG ACT GTC TCT AGC AAC
FR2>
AGT GCT GCT TGG AAC TGG ATC AGG
-- --- --- --- --- --- --- ---
CDR2>
TGG CTG GGA ACC ACA TAG TAG AGG
---
---
--- --- --- --- --- ---
80
GAG TTC TCC CTG GAG CTG AAC TCT
TAT TAG TGT GCA AGA GA
--- --- --- --- --- --
--- --- --- --- --- --
--- --- --- --- --- --
--- --- --- --- ---
CDR2
70
CDR3
VTPEDTAVYYCARELaDAFDIWGQGTKVTVSS
-------------- ETGL--Y----- L----
-----------------G . .------ ..-- .-
-- .----------
￿
GDQG- .Y-----L--- . .
40
GAG TCC CCA TCG AGA GGC CTT GAG
--- --- --- --- --- --- ---
-- -- --- --- --- ---
60
TCC AAG TGG TAT AAT CAT TAT CCA
- --- --- --- --- -- --- ---
--- --- --- --- --- --- -
---
￿
- . .
￿
.--
￿
-
￿
-- --
￿
---
￿
___
FR3>
GTA TCT GTG AAA ACT CGA ATA ACC ATC AAC CCA GAC ACA TCC AAG AAC
90
GTG ACT CCC GAG GAG ACC GCT GTG
either a 5' primer (TL20) specific for CDR3 ofthe germline VH6 gene or a5' primer
(TL21) specific for CDR3 of the "mutated" VH6 gene (Fig. 3). With the 3' germ-
line/5' germline primer combination, amplification from normal granulocyte DNA
ofthe A431 donor generated a band of expected size (135 bp; Fig. 3 B, lane 1) that
hybridized to the VH6 probe (Fig. 3 C, lane 1); but the 3' germline/5' mutated
primer combination failed to generate a VH6 hybridizingband from this DNA (Fig.
3, Band C, lanes2). However, fromA431 DNA the3' germline/5' mutatedcombina-
tion primed amplification ofthe expected 135-bp VH-6 hybridizing band (Fig. 3,
B and C, lanes 3). Together, these data demonstrate that the mutated sequence exists
CDR1
QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWNWIRQSOS
------------------------- .----- L------------
-------------------- .---- .--- . . . . .F-- . .-----
RGLEWLGRTYYRSKWYNDYAVSVKSRITINPDTSKNQFSLQLNS
--------------------------------------------
------- . . .-K-- . . . . .-E--------- .- .. .--:-- . .--
---. .----- .--- .NTN-. .---- .. .T- .----. .. . . .---
FIGURE 1.
￿
Nucleotide sequence ofex-
pressed VH6genes. Thenucleotide se-
quence of four VH6 cDNAs is com-
paredwith thesequence ofapreviously
published germline VH6 sequence
(6-1G1). Dashes indicate nucleotide
identity.
FIGURE 2. Amino acid sequence compar-
ison of expressed VH-6 genes. The single-
letter amino acid code is used. Dashes indi-
cate identity with the sequence of clone
F19L16.LOGTENBERG ET AL .
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FIGURE 3 .
￿
PCR Analysis of somatic mutation in expressed VH6 Genes . (A) Diagramatic
representation ofthe prototypic germlineVH6gene with locations and directions ofPCR primers
TL20,TL21 (5'end primers) andTL22 (3' end primer) . (B) Ethidium bromide-stained gel showing
amplified product . (C) Southern blots showing specific amplified products after probing with
'2P-labeled VH6 probe . GenomicDNA was isolated from cell line A431 and from granulocytes
ofthe donor from whom the cell line was established . (B)Lane 1, granulocyteDNAwith primers
TL 20 and TL22 ; lane 2, granulocyteDNAwith TL21 and TL22 . Lane 3, A431 cell lineDNA
with TL21 and TL22 ; lane 4, same as lane 1 without Taq I polymerase ; lane 5, same as lane
3 without Taq I polymerase . (C) Lanes are numbered as in B .
in the DNA of the A431 line but not in normal granulocytes from the same donor .
Therefore, the nucleotide sequence substitutions in cell line A431 (and most likely
in A10) result from somatic mutations . The pattern and extent of replacements in
the A431 and A10VH regions suggest that these mutations were selected over mul-
tiple generations, characteristic ofmemory Bcells (24, 25) . However, unlikememory
B cells, A10 and A431 have undergone somatic mutation in the absence of isotype
switching . BecauseTcells play an important role in directing switching, this obser-
vation might reflect absence of adequateT cell help for VH6-expressing B cells in
healthy individuals . Also, it is notable that the A10 and A431 antibodies bind with
high relative avidity to nDNA, a property not displayed by antibodies that express
the germline VH6 segments; this property may reflect the mutations and/or contri-
butions from the light chains in these antibodies (26) .1352
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Conservation of CDR3 Length.
￿
All four of the characterized VHDHjH rearrange-
ments contained short DH segments, ranging from 9-12 by in length (Fig. 4). DH
segments from L16 and A10 share extensive sequence homology with the DHQ52
germline sequence; the DHQ52 is the most JH-proximal germline DH segment (27)
and is used frequently in EBVtransformed human fetal liver pre-B cells (28). The
DH segments used in A431 and MLl rearrangements could not be unequivocally
identified but also could have arisen from DHQ52 rearrangement and N-region in-
sertions. The CDR3 regions in the four VH6 Ig heavy chains show extensive varia-
tion in amino acid sequence but are conserved in length in A10, L16, and MLl. The
length of CDR3 of A431 differs by only one amino acid residue. Conservation of
CDR3 length is notaproperty of human anti-DNA autoantibodies per se; extensive
variation in CDR3 length hasbeen found in anti-DNA antibodies that use members
of differentVH families (29, 30). However, conserved CDR3 length has been noted
to be characteristic of certain rheumatoid factors of mice and man (31, 32) and of
antibodies that predominate in some well-studied murine immune responses (reviewed
in reference 33). Such constraints on heavy chain CDR3-length may reflect regula-
tory and/or functional (antigen-binding) aspects of antibodies (33, 34).
Several features of the VH6 gene segment suggest a significant function for anti-
bodies it encodes: (a) The germline VH6 gene segment is extremely well conserved
at the nucleotide level in the human population; (6) The germline VH6 segment en-
codes polyreactive anti-DNA antibodies that also bind additional (auto)antigens;
(c) Somatically mutated VH6 genes are contained within autoantibodies that bind
with high avidity to native DNA, a property of antibodies diagnostic for SLE (28).
(d) Based on conserved CDR3 length, VH6 antibodies may be highly selected. In
addition, the VH6 gene family previously has been found to be unique in several
ways: it has only one member (6) and that member is the most JH proximal of all
known human VH segments (6, 22). In this regard, the organization of Ig heavy
chain VH genes influences their representation in primary antibody repertoires
(reviewedin reference35); for example, differentiating fetal murine pre-B cellspref-
erentially rearrange and, as a result, express JH-proximal VH gene segments (36).
Similar to proximal murine VH gene segments, the VH6 gene appears to be prefer-
entially expressed in fetal liver versus adultperipheral bloodlymphocytes (Berman,
J., andF Alt; manuscript in preparation). Significantly, studies ofmurine antibodies
that useJH-proximal VH genes demonstrated that a high proportion exhibit binding
to self-antigens (37, 38) leading to the proposal that some such antibodies play a
role in the early establishment of the murine B cell repertoire (38, 39).
Clone VH DH 3H
L16
￿
AGA GAA CTG GGG GAT GCT TTT GAT ATC TGG GGC CAA GGG ACA ATG GTC ACC GTC TCT TCA
ML1
￿
ACA GAA GAA ACG GGG CTC TTT --C TA- --- --- --G --A --C C-- --- --- --- --C ---
A10
￿
AGA GAA CTG GGC GAT GGT TTT --- G-- --- --- --- --- --- --- --- --- --- --- ---
A431 AGA
￿
GGG CAT CAA GGC TTT --C TA- --- --- --G --A --C C-- --- --- --- --C ---
DHQ52
￿
TAA CTG GGGA
FIGURE 4.
￿
Nucleotide sequences ofVH6DJHjoins. Forcomparison, thesequence ofthegerm-
line DHQ52 segment is shown. Regions ofhomology with DHQ52 areunderlined. Dashes indi-
cate sequence homology.The molecular genetic origin of pathogenic autoantibodies in patients with SLE
is unknown; they may derive from "natural" autoantibodies encoded by germline
V genes present in every healthy individual (40, 41) or they may result from somatic
mutations of V genes that encode other specificities (42). The VH6-expressing B
cells isolated in this study were not associatedwith autoimmune disease; therefore,
additional factors must be required for expansion and/or activation of B cells that
secrete pathogenic autoantibodies. Because the VH6-encoded heavy chain appears
to be the main contributor to the DNA-binding properties ofthe antibodies we tested,
introduction of a functionally rearranged VH6 gene segment into transgenic mice
may generate a population of B cells that express VH6-encoded autoantibodies. Such
a mouse model may be useful in the study of factors that contribute to the genera-
tion of "autoagressive" antibodies and autoimmune disease.
Summary
Little is known about the utilization of human Ig heavy chain variable gene seg-
ments (VH segments) in different B-lineage cell populations or in antibodies of par-
ticular specificity and function. We now demonstrate that human antibodies with
Ig VH regions encoded by the most JH-proximal human VH segment (VH6) have
specificities resembling those of autoantibodies present in sera of patients with sys-
temic lupus erythematosus (e.g., anti-DNA and anticardiolipin). These specificities
appear to be encoded by the germline VH6 gene because the activity was found in
multiple independent VH6 antibodies in which the light chain varied with respect
to isotype and Vrc subgroup. Features of CDR3 length and somatic mutation pat-
terns in several VH6 antibodies suggested that they were selected by the immune
system.
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